ProPhase Labs in the US stock market rose over 35%, with a market value reaching 15.78 million dollars

ChainCatcher news, according to Rockflow data, the US medical technology company ProPhase Labs surged over 35% during the trading session, with a market capitalization rising to $15.78 million. It had once increased by over 40% in pre-market trading.

ProPhase Labs announced on July 21 that it is exploring a reverse merger with a company focused on cryptocurrency and will begin holding Bitcoin as part of a new digital asset reserve strategy.